^
BIOMARKER:

FGFR2 fusion

i
Other names: FGFR2, BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25, Fibroblast growth factor receptor
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
FGFR2 fusion
Cholangiocarcinoma
pemigatinib
Sensitive
:
A1
PRNewswire - 1 week - (New A1)
FGFR2 fusion
Cholangiocarcinoma
ARQ 087
Sensitive
:
C2
ESMO 2022 - 3 weeks - (New C3)
FGFR2 fusion
Cholangiocarcinoma
infigratinib
Sensitive
:
A1
FGFR2 fusion
Cholangiocarcinoma
TAS 120
Sensitive
:
B
FGFR2 fusion
Solid Tumor
infigratinib
Sensitive
:
C1
FGFR2 fusion
Glioma
infigratinib
Sensitive
:
C1
FGFR2 fusion
Gastric Cancer
infigratinib
Sensitive
:
C1
FGFR2 fusion
Breast Cancer
infigratinib
Sensitive
:
C1
FGFR2 fusion
Hepatocellular Cancer
infigratinib
Sensitive
:
C1
FGFR2 fusion
Gastric Cancer
ARQ 087
Sensitive
:
C2
FGFR2 fusion
Gastrointestinal Cancer
ARQ 087
Sensitive
:
C2
FGFR2 fusion
Solid Tumor
Debio 1347
Sensitive
:
C3
FGFR2 fusion
Urothelial Cancer
erdafitinib
Sensitive
:
C3
FGFR2 fusion
Cholangiocarcinoma
Debio 1347
Sensitive
:
C3
FGFR2 fusion
Colon Cancer
Debio 1347
Sensitive
:
C3
FGFR2 fusion
Cholangiocarcinoma
ICP-192
Sensitive
:
C3
FGFR2 fusion
Cholangiocarcinoma
FGFR inhibitor
Sensitive
:
C3